Literature DB >> 29696573

ReShape Intragastric Balloon Complicated by Gastric Perforation and Peritonitis.

Aleksandr Kalabin1, Vishnu R Mani2, Anant Dinesh1, Paritosh Suman1, Leaque Ahmed1.   

Abstract

BACKGROUND: Obesity is a growing global epidemic with tremendous financial burden and health care costs worldwide. Restrictive surgery has emerged as the definitive treatment option to combat morbid obesity and its associated comorbidities. The advent of endoscopy has new grounds in obesity with the introduction of inflatable balloon placed in the stomach that decreases satiety by volume restriction.
MATERIALS AND METHODS: We report a first case of gastric perforation with peritonitis after ReShape intragastric balloon placement that needed emergent surgical intervention. Decision was made to proceed with exploratory laparotomy, device deflation, and removal with subsequent gastric defect repair.
RESULTS: Postoperative period was uneventful, drain was removed on postoperative day 2, and patient tolerated diet and was discharged home subsequently. Biopsy of the perforation site demonstrated mild non-specific chronic gastritis.
CONCLUSION: In the modern era of minimal invasiveness, any new approach would roar popularity among patients and hence is of utmost importance for clinicians to be constantly educated on scientific research and innovations in their field.

Entities:  

Keywords:  Endoscopy; Intragastric balloon; Obesity; Perforation; ReShape; Weight loss

Mesh:

Year:  2018        PMID: 29696573     DOI: 10.1007/s11695-018-3276-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  9 in total

1.  Annual medical spending attributable to obesity: payer-and service-specific estimates.

Authors:  Eric A Finkelstein; Justin G Trogdon; Joel W Cohen; William Dietz
Journal:  Health Aff (Millwood)       Date:  2009-07-27       Impact factor: 6.301

Review 2.  Endoscopic bariatric therapies.

Authors:  Barham K Abu Dayyeh; Steven A Edmundowicz; Sreenivasa Jonnalagadda; Nitin Kumar; Michael Larsen; Shelby Sullivan; Christopher C Thompson; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2015-03-28       Impact factor: 9.427

Review 3.  Endoscopic Treatments for Obesity.

Authors:  Gregory Pajot; Gerardo Calderon; Andrés Acosta
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

4.  The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity.

Authors:  Jaime Ponce; George Woodman; James Swain; Erik Wilson; Wayne English; Sayeed Ikramuddin; Eric Bour; Steven Edmundowicz; Brad Snyder; Flavia Soto; Shelby Sullivan; Richard Holcomb; John Lehmann
Journal:  Surg Obes Relat Dis       Date:  2014-12-16       Impact factor: 4.734

5.  Analysis of safety and efficacy of intragastric balloon in extremely obese patients.

Authors:  Stephan Göttig; Markos Daskalakis; Sylvia Weiner; Rudolf A Weiner
Journal:  Obes Surg       Date:  2009-03-17       Impact factor: 4.129

Review 6.  Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.

Authors:  Iñaki Imaz; Carmen Martínez-Cervell; Elvira Elena García-Alvarez; Juan Manuel Sendra-Gutiérrez; Jesús González-Enríquez
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

Review 7.  Obesity and colorectal cancer.

Authors:  Marc Bardou; Alan N Barkun; Myriam Martel
Journal:  Gut       Date:  2013-03-12       Impact factor: 23.059

Review 8.  ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies.

Authors:  Barham K Abu Dayyeh; Nitin Kumar; Steven A Edmundowicz; Sreenivasa Jonnalagadda; Michael Larsen; Shelby Sullivan; Christopher C Thompson; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2015-07-29       Impact factor: 9.427

9.  Acute Pancreatitis with Splenic Infarction as Early Postoperative Complication following Laparoscopic Sleeve Gastrectomy.

Authors:  Aleksandr Kalabin; Vishnu R Mani; Ankita Mishra; Hector Depaz; Leaque Ahmed
Journal:  Case Rep Surg       Date:  2017-04-13
  9 in total
  1 in total

1.  Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.

Authors:  B Betzel; M I Cooiman; E O Aarts; I M C Janssen; P J Wahab; M J M Groenen; J P H Drenth; F J Berends
Journal:  Surg Endosc       Date:  2019-03-14       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.